8-K: Research Solutions Q1 FY26: ARR Up 21%, Strong Profit Growth

Research Solutions reported robust first quarter fiscal year 2026 results, highlighted by a 21% increase in Annual Recurring Revenue to $21.3 million and significant growth in net income and Adjusted EBITDA.

Summary

• Annual Recurring Revenue (ARR) increased 21% year-over-year to $21.3 million, comprising $14.8 million in B2B and $6.5 million in B2C recurring revenue.
• Net B2B ARR growth was $561,000, representing over a 300% increase from the prior year and the best organic Q1 performance in company history.
• Platform revenue grew 18% to $5.1 million, now accounting for 42% of total revenue, up from 36% in the prior-year quarter.
• Total revenue for the quarter was $12.3 million, a 2% increase year-over-year.
• Gross profit rose 8% to $6.2 million, with total gross margin improving 270 basis points to 50.6%.
• Net income increased 12% to $749,000, or $0.02 per diluted share, compared to $669,000 in the prior-year quarter.
• Adjusted EBITDA increased 16% to $1.5 million, marking the second-best EBITDA quarter in company history.
• Cash flow from operations increased 31% to $1.1 million.
• Transaction revenue decreased 6.8% to $7.2 million due to lower per article fees, and transaction active customer count decreased 4.6% to 1,326.
• Sales and marketing expenses increased 40.0% to $1.67 million, while general and administrative expenses decreased 13.2% to $1.68 million.

Sentiment

Score: 8

Explanation: The company reported strong growth in key strategic metrics like ARR, platform revenue, net income, and Adjusted EBITDA, alongside robust cash flow. While transaction revenue and customer count declined, the shift towards higher-margin platform business is positive. The significant B2B ARR growth and achievement of the second-best EBITDA quarter indicate strong operational performance and strategic execution.

Positives

• Annual Recurring Revenue (ARR) increased 21% to $21.3 million, indicating strong subscription business growth.
• Net B2B ARR growth of $561,000 was up over 300% year-over-year, marking the best organic Q1 performance in company history.
• Platform revenue grew 18% to $5.1 million, increasing its contribution to total revenue from 36% to 42%.
• Gross profit increased 8% to $6.2 million, and total gross margin improved 270 basis points to 50.6%, driven by the shift to higher-margin platform business.
• Net income rose 12% to $749,000, demonstrating improved profitability.
• Adjusted EBITDA increased 16% to $1.5 million, representing the second-best EBITDA quarter in company history.
• Cash flow from operations increased 31% to $1.1 million, indicating strong operational cash generation.
• Average Sales Price (ASP) for B2B platforms is near all-time high levels, reaching $12,454.
• Successful acquisition of multiple six-figure deals, including the largest ever Scite AI deal, driven by new platform capabilities.
• Reduced general and administrative expenses by 13.2% and stock-based compensation by 49.2%.

Negatives

• Total revenue only increased 2% to $12.3 million, primarily due to a decline in transaction revenue.
• Transaction revenue decreased 6.8% to $7.2 million, attributed to lower per article fees on paid orders.
• Transaction active customer count decreased by 64 customers, or 4.6%, to 1,326.
• B2C Incremental ARR was negative, decreasing by $186,159, compared to a positive increase in the prior year.
• Cash and cash equivalents decreased from $12,227,312 at June 30, 2025, to $11,955,763 at September 30, 2025.

Risks

• Forward-looking statements are subject to risks, uncertainties, and assumptions that are difficult to predict, estimate, or verify, potentially causing actual results to differ materially and adversely.
• Specific risk factors are referenced as being described in the Company's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, though not detailed in this filing.

Future Outlook

The company anticipates continued progress in its transformation towards SaaS and AI solutions, expecting enhanced product offerings, additional customers, and sustained growth. Management aims to reinvest strong cash flow into sales and marketing to drive better execution and deliver long-term shareholder value, while also making incremental progress towards its 'Rule of 40' target.

Management Comments

• "Our first quarter results show the continued progress of our transformation toward award winning SaaS and AI solutions."
• "We posted the strongest organic Q1 growth on record within our B2B business, aided by winning multiple six-figure deals, including our largest ever Scite AI deal, which are being driven in part by the new capabilities offered within our Article Galaxy and Scite platforms, including API access, an AI rights add-on and the launch of Scite rankings."
• "With these deals our Average Sales Price (ASP) is now near all-time high levels."
• "We also continue to make incremental progress towards our Rule of 40 target, thanks to a 21% year-over-year increase in total ARR and our second-best EBITDA quarter in Company history."
• "Lastly, the business continues to generate strong cash flow, placing us in a very strong position to reinvest into our sales and marketing efforts to further drive better execution and deliver for our shareholders."

Industry Context

Research Solutions operates in the rapidly evolving market for scientific, technical, and medical (STM) content, leveraging its position as a publisher-independent marketplace. The company's focus on AI-powered research workflow platforms, including its Article Galaxy and Scite platforms, aligns with broader industry trends emphasizing digital transformation, automation, and artificial intelligence to enhance research efficiency and discovery. The strong growth in platform revenue and B2B ARR suggests successful adaptation to the increasing demand for SaaS and AI solutions in academic and life science sectors, contrasting with a decline in traditional transaction-based revenue.

Comparison to Industry Standards

• The company is making "incremental progress towards our Rule of 40 target," a common SaaS industry benchmark for balancing growth and profitability (revenue growth rate + EBITDA margin should ideally be 40% or higher).
• The filing does not provide specific comparisons to named competitors or projects, but the strong organic B2B ARR growth and high ASP suggest competitive strength in its niche.

Stakeholder Impact

• Shareholders: Positive impact due to strong growth in ARR, net income, Adjusted EBITDA, and cash flow from operations, indicating improved financial health and potential for long-term value creation. Management explicitly states a goal to "deliver for our shareholders."
• Customers (B2B): Positive impact from enhanced AI-powered platforms, new capabilities (API access, AI rights add-on, Scite rankings), and successful six-figure deals, suggesting improved service and value.
• Customers (Transaction-based): Potential negative impact due to a decrease in transaction revenue and active customer count, possibly indicating a shift away from this segment or competitive pressures.
• Employees: Increased investment in sales and marketing could imply growth opportunities, though not explicitly stated.
• Creditors: Strong cash flow from operations and improved profitability enhance the company's financial stability.

Next Steps

• Host a conference call on November 13, 2025, at 5:00 p.m. ET to discuss the results.
• Reinvest strong cash flow into sales and marketing efforts to drive better execution and deliver for shareholders.
• Continue progress towards the "Rule of 40" target.
• Further enhance product offerings and acquire additional customers.

Key Dates

Recommendation

The filing demonstrates a strong strategic pivot towards high-margin SaaS and AI solutions, evidenced by a 21% increase in total ARR and an exceptional 300%+ growth in net B2B ARR, which is the best organic Q1 performance in company history. The significant improvements in gross margin (up 270 bps to 50.6%), net income (up 12%), and Adjusted EBITDA (up 16% to the second-best quarter ever) highlight robust operational efficiency and profitability. Furthermore, the 31% increase in operating cash flow provides ample liquidity for reinvestment into growth initiatives. While transaction revenue declined, this is offset by the strategic shift to the higher-growth, higher-margin platform business. The company's progress towards the 'Rule of 40' target and successful large AI deals position it favorably in the evolving research workflow market. These results indicate strong execution and significant future growth potential, making it an attractive investment.

Keywords

Research Solutions, RSSS, SEC Filing, Financial Results, Q1 2026, Annual Recurring Revenue, ARR, Platform Revenue, SaaS, AI, Artificial Intelligence, Research Workflow, STM Content, Scientific Research, Adjusted EBITDA, Net Income, Cash Flow, Corporate Governance, Nasdaq Capital Market